Journal of Stroke and Cerebrovascular Diseases

Neurocognitive outcomes and survival with high- vs low-intensity statins in stroke survivors: A propensity score-matched cohort (2010-2025)

By Anwar Zahran, Mohammad Bdair, Fathi S Milhem, Shahd Aldarak

Cohort study of 254,711 peopleInterventions

The paper

Anwar Zahran, Mohammad Bdair, Fathi S Milhem, Shahd Aldarak

An-Najah National University

Journal of Stroke and Cerebrovascular Diseases, 3 Aug 2026

doi.org/10.1016/j.jstrokecerebrovasdis.2026.108721 PubMed 42546862

Journal of Alzheimer's Disease Reports4 Oct 2026
Statins cut Alzheimer's risk but raise other dementia risks
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Drugs & Aging4 Oct 2026
RAS inhibitors linked to lower dementia risk than CCBs
Frontiers in Aging Neuroscience4 Oct 2026
COVID-19 tied to higher dementia risk in older adults with diabetes